Mellors J, Carroll M
Cell Mol Life Sci. 2024; 81(1):22.
PMID: 38200235
PMC: 10781860.
DOI: 10.1007/s00018-023-05074-2.
Merkuleva Y, Shcherbakov D, Ilyichev A
Russ J Bioorg Chem. 2022; 48(2):256-272.
PMID: 35637780
PMC: 9134727.
DOI: 10.1134/S1068162022020169.
Cooper N, Welsh Jr R
Springer Semin Immunopathol. 2020; 2(3):285-310.
PMID: 32214620
PMC: 7087519.
DOI: 10.1007/BF00198721.
Bottermann M, Foss S, Caddy S, Clift D, van Tienen L, Vaysburd M
Cell Host Microbe. 2019; 25(4):617-629.e7.
PMID: 30926239
PMC: 6461443.
DOI: 10.1016/j.chom.2019.02.016.
Calvert A, Boroughs K, Laven J, Stovall J, Luy B, Kosoy O
J Clin Microbiol. 2018; 56(6).
PMID: 29618505
PMC: 5971560.
DOI: 10.1128/JCM.00234-18.
Functions of Antibodies.
Forthal D
Microbiol Spectr. 2014; 2(4):1-17.
PMID: 25215264
PMC: 4159104.
Complement protein C1q reduces the stoichiometric threshold for antibody-mediated neutralization of West Nile virus.
Mehlhop E, Nelson S, Jost C, Gorlatov S, Johnson S, Fremont D
Cell Host Microbe. 2009; 6(4):381-91.
PMID: 19837377
PMC: 2782387.
DOI: 10.1016/j.chom.2009.09.003.
Complement modulates pathogenesis and antibody-dependent neutralization of West Nile virus infection through a C5-independent mechanism.
Mehlhop E, Fuchs A, Engle M, Diamond M
Virology. 2009; 393(1):11-5.
PMID: 19744691
PMC: 2753729.
DOI: 10.1016/j.virol.2009.08.019.
Natural antibody and complement mediate neutralization of influenza virus in the absence of prior immunity.
Jayasekera J, Moseman E, Carroll M
J Virol. 2007; 81(7):3487-94.
PMID: 17202212
PMC: 1866020.
DOI: 10.1128/JVI.02128-06.
Scanning and transmission electron microscopic studies of complement-mediated lysis and antibody-dependent cell-mediated cytolysis of herpes simplex virus-infected human fibroblasts.
Daniels C, Bodner S, Trofatter Jr K
Am J Pathol. 1980; 100(3):663-82.
PMID: 7416235
PMC: 1903561.
The complement system: its importance in the host response to viral infection.
Hirsch R
Microbiol Rev. 1982; 46(1):71-85.
PMID: 7045625
PMC: 373211.
DOI: 10.1128/mr.46.1.71-85.1982.
Biological functions of monospecific antibodies to envelope glycoproteins of Newcastle disease virus.
Umino Y, Kohama T, Kohase M, Sugiura A, Klenk H, Rott R
Arch Virol. 1984; 81(1-2):53-65.
PMID: 6743025
DOI: 10.1007/BF01309296.
Measurement of modulation of mouse complement levels in vivo, utilizing a microtiter hemolytic assay.
White Jr K, Anderson A
Agents Actions. 1984; 15(5-6):562-8.
PMID: 6532179
DOI: 10.1007/BF01966775.
Complement, viruses, and virus-infected cells.
Cooper N, Nemerow G
Springer Semin Immunopathol. 1983; 6(4):327-47.
PMID: 6364429
PMC: 7087538.
DOI: 10.1007/BF02116278.
Mouse immunoglobulin antibodies require complement for neutralization of mouse retroviruses.
Sarma P, Rowe W
J Virol. 1983; 45(3):956-60.
PMID: 6300466
PMC: 256501.
DOI: 10.1128/JVI.45.3.956-960.1983.
Neutralization of Epstein-Barr virus by nonimmune human serum. Role of cross-reacting antibody to herpes simplex virus and complement.
Nemerow G, JENSEN F, Cooper N
J Clin Invest. 1982; 70(5):1081-91.
PMID: 6290536
PMC: 370321.
DOI: 10.1172/jci110696.
Microneutralization test for influenza A and B and parainfluenza 1 and 2 viruses that uses continuous cell lines and fresh serum enhancement.
Frank A, Puck J, Hughes B, CATE T
J Clin Microbiol. 1980; 12(3):426-32.
PMID: 6260835
PMC: 273601.
DOI: 10.1128/jcm.12.3.426-432.1980.
The in vivo behaviour of complement-coated red cells: studies in C6-deficient, C3-depleted and normal rabbits.
Brown D, LACHMANN P, Dacie J
Clin Exp Immunol. 1970; 7(3):401-21.
PMID: 5477937
PMC: 1712743.
Significance of bivalence of antibody in viral neutralization.
Rosenstein R, Nisonoff A, UHR J
J Exp Med. 1971; 134(6):1431-41.
PMID: 5166611
PMC: 2139105.
DOI: 10.1084/jem.134.6.1431.
[Complement dependent neutralization of equine arteritis virus. Brief report].
Maess J
Arch Gesamte Virusforsch. 1971; 33(1):194-6.
PMID: 4996685